~~<i id='E410A0FD86'><strike id='E410A0FD86'><tt id='E410A0FD86'><pre id='E410A0FD86'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- explore
Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
log on

focus

entertainment

author：knowledge 2025-09-27 21:54:54 - browse：1826

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： UnitedHealth, Optum discontinue NaviHealth name

hotspot

entertainment

hotspot

Wikipedia

focus

explore

GeorgeYancopoulosonthe2024BreakthroughSummitEaststageSTATGeorgeYancopoulosisintouchwithhisteenagesel

WSS

FDA clears Verve to begin U.S. study of gene

Yancopoulos of Regeneron works to expand Dupixent success

The problems with dementia villages

CZI to create biohub to build anti

Bring on the sabbaticals for nurses

Medical devices makers are asking for forgiveness, not permission

focus

entertainment

hotspot

Medicare details structure of new drug price negotiation program

Steward Health Care expansion into Malta flopped

New air purifier tech could be key to improving indoor air quality

Roche drug slashes death risk in early

Supreme Court strikes down use of affirmative action

Chinese researcher claims birth of first gene

Bright Health sells Medicare Advantage business to Molina

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Wildfire smoke exposes gaps in outdoor worker protections

Smaller biotechs seek to piggyback on weight loss drug boom

entertainment

Roche acquires Telavant from Roivant, adding experimental IBD treatment

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

What Kate Middleton's cancer revelation might teach the world

Questions loom on AstraZeneca cancer drug as safety concerns ebb

This gene therapy has record $4.25 million price. It's saved children.

hotspot

Wikipedia

focus

explore